Bone Sarcoma Clinical Trials
3 recruiting trials for Bone Sarcoma. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Bone Sarcoma clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Mayo Clinic (2), Memorial Sloan Kettering Cancer Center (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Toronto Extremity Salvage Score (behavioral, 1 trial), followed by Musculoskeletal Tumor Society Score, Timed Get Up and Go Test.
Track Bone Sarcoma trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
The purpose of this study is to look at the amount of function that returns in participants that have reconstruction with bone graft or artificial device and in participants who...
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
This study compares carbon ion therapy, surgery, and proton therapy to determine if one has better disease control and fewer side effects. There are three types of radiation...
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With...
This study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Bone Sarcoma, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Bone Sarcoma, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Bone Sarcoma, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.